Background: Given the dismal prognosis of metastatic pancreatic ductal adenocarcinoma, oligometastatic disease (OM-PDAC) has emerged as a distinct clinical entity, challenging systemic-only paradigms via advanced multimodal thera... ...

请注册登录后继续浏览